Navigation Links
Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries
Date:11/11/2008

New Data Suggest Potential Benefits of Targeted Tissue Cooling During

Prostate Surgery

SAN DIEGO, Nov. 11 /PRNewswire-FirstCall/ -- Cardium Therapeutics (Amex: CXM) and its operating unit InnerCool Therapies, Inc., today announced that it has developed a pelvic cooling catheter system called UroCool(TM), which is designed to induce localized cooling during surgery for prostate cancer (radical prostatectomy). The new technology is being applied in collaboration with renowned prostate surgeon, Thomas E. Ahlering, M.D., Professor and Vice Chair of the Department of Urology at the University of California, Irvine and is the subject of an exclusive licensing agreement with the University of California. A regulatory application for FDA 510(k) clearance of InnerCool's UroCool(TM) catheter is expected to be submitted in the first quarter of 2009.

(Logo: http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO)

Dr. Ahlering and his colleague Dr. David S. Finley are conducting clinical studies designed to demonstrate safety and confirm the potential benefits of localized cooling during robotic-assisted prostatectomy, which is now the most common surgical technique for prostate cancer. The UroCool(TM) catheter is designed to be placed within the rectal cavity adjacent to the prostate during surgery. UroCool is used in conjunction with InnerCool's Celsius Control Console which circulates cold saline in a closed loop within the catheter to allow for localized cooling. Drs. Ahlering and Finley believe that therapeutic cooling during prostate surgery (which includes both traditional open surgical approaches and the newe
'/>"/>

SOURCE Cardium Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Cardium Announces FDA 510(K) Clearance of InnerCools RapidBlue(TM) Endovascular System
2. Cardium Announces InnerCools New RapidBlue(TM) System Obtains CE Mark for Commercial Sale in Europe and UL certification
3. Cardiums InnerCool Therapies Unit Announces Italian Commercialization Agreement for Portfolio of Temperature Modulation Systems
4. Cardium Reports on Science Channel Series Featuring InnerCools Endovascular Cooling During Brain Surgery at Stanford University
5. Cardiums InnerCool Therapies Unit Announces European Commercialization Agreement for Portfolio of Temperature Modulation Systems
6. Tianyin Pharmaceutical Co., Inc. Announces First Quarter 2009 Financial Results
7. China Biologic Products Announces Third Quarter 2008 Results Conference Call
8. Synvista Therapeutics Announces Data Further Demonstrating the Value of Haptoglobin Genotyping in Diabetic Patients During AHA Meeting
9. Heritage Labs Announces A1c Test Certification Milestone
10. Nventa Biopharmaceuticals Announces Third Quarter 2008 Financial Results and Recent Corporate Highlights
11. The Binding Site Announces Trading Update for Year Ended September 30th 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Wilmington, DE (PRWEB) January 22, 2015 ... the Pistoia Alliance, which helps companies check the legal ... set to expand to China. , As their ... companies are globally adopting software solutions built as a ...
(Date:1/22/2015)... Nueva Jersey , 22 de enero de 2015 ... Research abre hoy su llamada a nominaciones para 2015. ... científica ha hecho, o tiene el potencial para hacer, ... Las nominaciones se aceptarán hasta el 15 de marzo ...
(Date:1/22/2015)... , a precision medicine software company that has developed a ... genomic, imaging and other biomedical data in research and clinical ... CEO of Aspera, an IBM Company, to its board as ... "We are pleased to welcome Michelle to ...
(Date:12/24/2014)... , Dec. 24, 2014  United Therapeutics Corporation (NASDAQ: ... MDT ) has submitted a pre-market approval ... for the use of Medtronic,s SynchroMed ® II ... for use with United Therapeutics, Remodulin ® (treprostinil) ...
Breaking Biology Technology:Global Compliance Service for Controlled Substances to Expand to China 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 3El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 4GenoSpace Expands Board with Appointment of Michelle Munson 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4
... N.C., June 10 Campbell Alliance, the leading,management ... today announced that executives from the firm,s Trade ... Business Intelligence,(CBI) 4th Annual Commercial Contracts and Chargeback ... June 19-20, 2008, at,the Hyatt Regency Philadelphia at ...
... (OTC,Bulletin Board: AGGX.OB) a New York-based biotechnology company, ... anti-angiogenic drugs, announced the,appointment of William Garland PhD ... La Roche, Inc., has directed research and,development programs ... such as,Centaur Pharmaceuticals, Atairgin Technologies, Lpath Therapeutics, Inc.,(LPTN.OB) ...
... Therapeutics Inc. is extremely,pleased to announce the initiation ... IAP,("Inhibitor of Apoptosis Protein") inhibitor, HGS1029 (formerly AEG40826),as ... This small,molecule IAP inhibitor was developed by Aegera ... HGSI ) for oncology development in December 2007. ...
Cached Biology Technology:Campbell Alliance Trade and Distribution Practice to Speak at CBI's Commercial Contracts and Chargeback Management Conference 2Campbell Alliance Trade and Distribution Practice to Speak at CBI's Commercial Contracts and Chargeback Management Conference 3AngioGenex Appoints New CEO to Direct Development of Anti-Cancer Drugs 2AngioGenex Appoints New CEO to Direct Development of Anti-Cancer Drugs 3Aegera Therapeutics collaboration with Human Genome Sciences leads to the initiation of a Phase 1 clinical trial with lead IAP inhibitor HGS1029 and receipt of first milestone payment 2
(Date:12/17/2014)... RALEIGH, N.C. , Dec. 16, 2014 Valencell, ... licensed its PerformTek biometric technology to industry leaders such ... highly accurate, clinically validated, biometric wearable products. These products ... 6-9 in Las Vegas . ...
(Date:12/11/2014)... and Markets , http://photos.prnewswire.com/prnh/20130307/600769 ... the addition of the "Biometrics Market in the ... One major trend emerging in this market is ... is important to upgrade biometric solutions to the latest ...
(Date:12/10/2014)... been here before: you desperately need to sign into your online ... answer to your secret question. What,s your dog,s birthday? Who was ... , a digital infrastructure security company, launches the app ... with usernames, passwords and PINs – 1U TM . ...
Breaking Biology News(10 mins):Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3
... BOULDER--The use of prescribed burns to manage Western ... footprint. A new study finds that such burns, often ... bigger trees, release substantially less carbon dioxide emissions than ... prescribed burns can be an important piece of a ...
... DC, March 16, 2010 A new study ... research institutions states that forest protection offers one ... to combat climate change. The study, "Indigenous Lands, ... in PLoS Biology , a peer-reviewed scientific ...
... UCSF researchers have discovered that a key cellular defect ... can lead to cancer susceptibility. The scientists also found ... in correcting this defect. According to the study ... fight against cancer and could affect treatment of lymphoma ...
Cached Biology News:Prescribed burns may help reduce US carbon footprint 2Prescribed burns may help reduce US carbon footprint 3Study highlights forest protected areas as a critical strategy for slowing climate change 2Blocking cancer in its path: New cellular defect discovered 2Blocking cancer in its path: New cellular defect discovered 3
Request Info...
Mouse monoclonal [3G131] to Desmoglein 1 ( Abpromise for all tested applications). entrezGeneID: 1828 SwissProtID: Q02413...
TCP-1 alpha (H-110)...
Synphilin 1 Immunogen: Synthetic peptide corresponding to residues S(829) L E L N G E K D K D K G R T L Q R T(847) of human Synphilin 1. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: